Benzinga | Nov 10, 2021 07:42AM EST

Finch Therapeutics Group Q3 EPS $(0.21) Up From $(1.22) YoY, Sales $11.34M Up From $1.77M YoY

Finch Therapeutics Group (NASDAQ:FNCH) reported quarterly losses of $(0.21) per share. This is a 82.79 percent increase over losses of $(1.22) per share from the same period last year. The company reported $11.34 million in sales this quarter. This is a 540.49 percent increase over sales of $1.77 million the same period last year.